BioDelivery Sciences International, Inc. (BDSI) Company Bio
BioDelivery Sciences International, Inc. engages in the development and commercialization of pharmaceutical products principally in the areas of pain management and addiction. The company was founded in 1997 and is based in Raleigh, North Carolina.
Background BioDelivery Sciences (BDSI) is a biotechnology company focusing on an opioid, Belbuca, that is less addictive than most other opioids on the market. They also have a drug to treat opioid-induced constipation, marketed as SYMPROIC. You can learn more from my other two articles on BDSI here and here....
Matthew Zeets on Seeking Alpha | September 4, 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock might be going. […]
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March 31st, near the height of the coronavirus market crash. In this article, we look at what those funds think […]